Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

Lorenzo Fornaro, Francesco Leone, Angélique Vienot, Andrea Casadei-Gardini, Caterina Vivaldi, Astrid Lièvre, Pasquale Lombardi, Emmanuele De Luca, Dewi Vernerey, Elisa Sperti, Gianna Musettini, Maria Antonietta Satolli, Julien Edeline, Rosella Spadi, Cindy Neuzillet, Alfredo Falcone, Giulia Pasquini, Mario Clerico, Alessandro Passardi, Paola BuscagliaAurélia Meurisse, Massimo Aglietta, Clémence Brac, Enrico Vasile, Francesco Montagnani

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan'. Together they form a unique fingerprint.

Medicine & Life Sciences